Cardio Diagnostics Holdings (CDIO) Enterprise Value (2021 - 2026)
Cardio Diagnostics Holdings (CDIO) posted Enterprise Value of -$7.1 million for Q1 2026, down 38.48% sequentially from -$5.1 million in Q4 2025, and up 26.96% YoY from -$5.6 million in Q1 2025.
Cardio Diagnostics Holdings (CDIO) Enterprise Value (2021 - 2026) Analysis & Trends
Cardio Diagnostics Holdings has reported Enterprise Value for 6 years, with the latest figure at -$7.1 million in Q1 2026.
- Quarterly Enterprise Value rose 26.96% year-over-year to -$7.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$7.1 million (up 26.96% YoY) and the FY2025 annual result came in at -$5.1 million, up 34.71% from the prior year.
- Enterprise Value fell to -$7.1 million in Q1 2026 per CDIO's latest filing, from -$5.1 million in the prior quarter.
- Over five years, Enterprise Value peaked at -$250000.0 in Q3 2025 and troughed at -$9.7 million in Q1 2025.
- A 5-year average of -$4.9 million and a median of -$5.0 million in 2023 frame the typical range for Enterprise Value.
- The sharpest annual moves came in 2022 and 2025: Enterprise Value tumbled 92493.82% in 2022, then soared 87.39% in 2025.
- Over 5 years, Enterprise Value stood at -$4.1 million in 2022, then soared by 68.83% to -$1.3 million in 2023, then sank by 509.84% to -$7.8 million in 2024, then jumped by 34.71% to -$5.1 million in 2025, then tumbled by 38.48% to -$7.1 million in 2026.
- According to Business Quant data, Enterprise Value over the past three periods registered -$7.1 million, -$5.1 million, and -$250000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | -5.18 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -5.14 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | -5.10 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | -3.31 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -1.16 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 2.12 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -18.39 Bn |
| 10 | Cardio Diagnostics Holdings | 6.42 Mn | 835,350.96 | - | -5.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -5.59 Mn |
| Mar 31, 2026 | -7.08 Mn |
| Dec 31, 2025 | -5.11 Mn |
| Sep 30, 2025 | -250,000.00 |
| Jun 30, 2025 | -7.97 Mn |
| Mar 31, 2025 | -9.69 Mn |
| Dec 31, 2024 | -7.83 Mn |
| Sep 30, 2024 | -1.98 Mn |
| Jun 30, 2024 | -1.31 Mn |
| Mar 31, 2024 | -1.56 Mn |
| Dec 31, 2023 | -1.28 Mn |
| Sep 30, 2023 | -3.63 Mn |
| Jun 30, 2023 | -5.04 Mn |
| Mar 31, 2023 | -6.71 Mn |
| Dec 31, 2022 | -4.12 Mn |
| Sep 30, 2022 | -8.96 Mn |
| Jun 30, 2022 | -9.66 Mn |
| Mar 31, 2022 | -310,241.00 |
| Dec 31, 2021 | -512,767.00 |
| Sep 30, 2021 | -9,681.00 |